BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30715424)

  • 1. Current approaches and future perspectives for advanced-stage follicular lymphoma with a low tumor burden.
    Fukuhara N; Ishizawa K
    Jpn J Clin Oncol; 2019 Apr; 49(4):306-310. PubMed ID: 30715424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.
    Reagan PM; Friedberg JW
    Curr Treat Options Oncol; 2015 Jul; 16(7):32. PubMed ID: 26031546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Updates in treatment strategies for follicular lymphoma].
    Fukuhara N
    Rinsho Ketsueki; 2020; 61(9):1252-1258. PubMed ID: 33162523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The current therapeutic landscape for follicular lymphoma].
    Kobayashi T
    Rinsho Ketsueki; 2021; 62(8):1070-1076. PubMed ID: 34497193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management strategy for follicular lymphoma].
    Fukuhara N
    Rinsho Ketsueki; 2017; 58(10):2020-2025. PubMed ID: 28978844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment strategies for follicular lymphoma].
    Fukuhara N
    Rinsho Ketsueki; 2023; 64(9):1019-1025. PubMed ID: 37899178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low grade lymphoma: research progress and questions about treatment].
    Ishizawa K
    Rinsho Ketsueki; 2015 Oct; 56(10):2039-46. PubMed ID: 26458443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follicular lymphoma: recent advances].
    Ando K
    Rinsho Ketsueki; 2018; 59(10):2104-2108. PubMed ID: 30305515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study.
    Martinelli G; Montoro J; Vanazzi A; Andreola G; Liptrott S; Radice D; Negri M; Preda L; Pruneri G; Laszlo D
    Hematol Oncol; 2015 Dec; 33(4):129-35. PubMed ID: 25047267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).
    Miyamoto K; Fukuhara N; Maruyama D; Shibata T; Nakamura K; Ishizawa K; Tsukasaki K; Nagai H;
    Jpn J Clin Oncol; 2018 Aug; 48(8):777-780. PubMed ID: 29901705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
    Rajguru S; Kristinsdottir T; Eickhoff J; Peterson C; Meyer CM; Traynor AM; Kahl BS
    Clin Adv Hematol Oncol; 2014 Aug; 12(8):509-15. PubMed ID: 25356575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies.
    Milunović V; Bogeljić Patekar M; Jakubac KM; Mandac Rogulj I; Radić-Krišto D; Planinc-Peraica A; Ostojić Kolonić S
    Acta Clin Croat; 2017 Mar; 56(1):143-156. PubMed ID: 29120553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab maintenance therapy: a step forward in follicular lymphoma.
    van Oers MH
    Haematologica; 2007 Jun; 92(6):826-33. PubMed ID: 17550856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
    Seiler T; Hiddemann W; Dreyling M
    Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pros and cons of rituximab maintenance in follicular lymphoma.
    Zhang L; Ghielmini M; Cheson BD; Ujjani C
    Cancer Treat Rev; 2017 Jul; 58():34-40. PubMed ID: 28628883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
    Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
    Br J Haematol; 2016 Mar; 172(5):724-34. PubMed ID: 26729445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is observation dead in follicular lymphoma? Still appropriate.
    Jacobson CA; Freedman AS
    J Natl Compr Canc Netw; 2015 Mar; 13(3):367-70. PubMed ID: 25736012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.